%0 Journal Article
%@ 1945-7197
%A Mujahid, S
%A Hunt, KF
%A Cheah, YS
%A Forsythe, E
%A Hazlehurst, JM
%A Sparks, K
%A Mohammed, S
%A Tomlinson, JW
%A Amiel, SA
%A Carroll, PV
%A Beales, PL
%A Huda, MSB
%A McGowan, BM
%D 2018
%F discovery:10069579
%J Journal of Clinical Endocrinology & Metabolism
%K Adolescent, Adult, Bardet-Biedl Syndrome, Body Mass Index, Case-Control Studies, Female, Hospitals, Humans, Insulin Resistance, Male, Metabolic Syndrome, Middle Aged, Obesity, Prevalence, Sample Size, Young Adult
%N 5
%P 1834-1841
%T The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population
%U https://discovery.ucl.ac.uk/id/eprint/10069579/
%V 103
%X Context: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder in which previous reports have described obesity and a metabolic syndrome. Objective: We describe the endocrine and metabolic characteristics of a large BBS population compared with matched control subjects. Design: We performed a case-control study. Setting: This study was performed at a hospital clinic. Patients: Study patients had a clinical or genetic diagnosis of BBS. Main Outcome Measurements: Our study determined the prevalence of a metabolic syndrome in our cohort. Results: A total of 152 subjects were studied. Eighty-four (55.3%) were male. Mean (± standard deviation) age was 33.2 ± 1.0 years. Compared with age-, sex-, and body mass index-matched control subjects, fasting glucose and insulin levels were significantly higher in subjects with BBS (glucose: BBS, 5.2 ± 1.2 mmol/L vs control, 4.9 ± 0.9 mmol/L, P = 0.04; insulin: BBS, 24.2 ± 17.0 pmol/L vs control, 14.2 ± 14.8 pmol/L, P < 0.001). Serum triglycerides were significantly higher in subjects with BBS (2.0 ± 1.2 mmol/L) compared with control subjects (1.3 ± 0.8 mmol/L; P < 0.001), but total cholesterol, high-density lipoprotein, and low-density lipoprotein were similar in both groups. Systolic blood pressure was higher in the BBS group (BBS, 135 ± 18 mm Hg vs control subjects, 129 ± 16 mm Hg; P = 0.02). Alanine transaminase was raised in 34 (26.8%) subjects with BBS, compared with five (8.9%) control subjects (P = 0.01). The rate of metabolic syndrome, determined using International Diabetes Federation criteria, was significantly higher in the BBS group (54.3%) compared with control subjects (26% P < 0.001). Twenty-six (19.5%) of male subjects with BBS were hypogonadal (serum testosterone, 9.9 ± 5.3 mmol/L), but significant pituitary abnormalities were uncommon. Subclinical hypothyroidism was present in 24 of 125 (19.4%) patients with BBS, compared with 3 of 65 (4.6%) control subjects (P = 0.01). Conclusions: Insulin resistance and the metabolic syndrome are increased in adult patients with BBS compared with matched control subjects. Increased subclinical hypothyroidism in the BBS cohort needs further investigation.
%Z This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.